File Download
There are no files associated with this item.
Links for fulltext
(May Require Subscription)
- Publisher Website: 10.1111/j.1756-185X.2008.00389.x
- Scopus: eid_2-s2.0-70349492398
- WOS: WOS:000266391800011
- Find via
Supplementary
- Citations:
- Appears in Collections:
Article: Treatment options for postmenopausal osteoporosis in asia
Title | Treatment options for postmenopausal osteoporosis in asia |
---|---|
Authors | |
Keywords | Bone mineral density Fracture Osteoporosis Postmenopausal Treatment |
Issue Date | 2008 |
Publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd |
Citation | International Journal Of Rheumatic Diseases, 2008, v. 11 n. 4, p. 386-392 How to Cite? |
Abstract | Treatment of osteoporosis has advanced dramatically during the past decade, with more therapeutic options than ever now available. Large-scale randomized placebo-controlled trials have documented the efficacy of a number of agents in reducing vertebral and non-vertebral fractures. Anti-resorptive agents (hormone replacement therapy, selective estrogen-receptor modulators, calcitonin and bisphosphonates) and bone-forming anabolic agents (parathyroid horomone and strontium ranelate) act via different mechanisms to reduce fractures and improve bone strength. In view of the high prevalence of calcium and vitamin D insufficiency in Asia, calcium and vitamin D supplementation remains a fundamental part of any treatment regimen, especially among the elderly. Given the high cost of these agents, a global assessment of the fracture risk of the patient is essential to determine the need for pharmacological treatment versus life-style modification and dietary supplementation in the management of postmenopausal osteoporosis in Asia. © 2008 Asia Pacific League of Associations for Rheumatology. |
Persistent Identifier | http://hdl.handle.net/10722/59370 |
ISSN | 2023 Impact Factor: 2.4 2023 SCImago Journal Rankings: 0.653 |
ISI Accession Number ID | |
References |
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Chu, EYW | en_HK |
dc.contributor.author | Tsang, SWY | en_HK |
dc.contributor.author | Kung, AWC | en_HK |
dc.date.accessioned | 2010-05-31T03:48:36Z | - |
dc.date.available | 2010-05-31T03:48:36Z | - |
dc.date.issued | 2008 | en_HK |
dc.identifier.citation | International Journal Of Rheumatic Diseases, 2008, v. 11 n. 4, p. 386-392 | en_HK |
dc.identifier.issn | 1756-1841 | en_HK |
dc.identifier.uri | http://hdl.handle.net/10722/59370 | - |
dc.description.abstract | Treatment of osteoporosis has advanced dramatically during the past decade, with more therapeutic options than ever now available. Large-scale randomized placebo-controlled trials have documented the efficacy of a number of agents in reducing vertebral and non-vertebral fractures. Anti-resorptive agents (hormone replacement therapy, selective estrogen-receptor modulators, calcitonin and bisphosphonates) and bone-forming anabolic agents (parathyroid horomone and strontium ranelate) act via different mechanisms to reduce fractures and improve bone strength. In view of the high prevalence of calcium and vitamin D insufficiency in Asia, calcium and vitamin D supplementation remains a fundamental part of any treatment regimen, especially among the elderly. Given the high cost of these agents, a global assessment of the fracture risk of the patient is essential to determine the need for pharmacological treatment versus life-style modification and dietary supplementation in the management of postmenopausal osteoporosis in Asia. © 2008 Asia Pacific League of Associations for Rheumatology. | en_HK |
dc.language | eng | en_HK |
dc.publisher | Wiley-Blackwell Publishing Asia. The Journal's web site is located at http://www.blackwell-synergy.com/loi/ijrd | en_HK |
dc.relation.ispartof | International Journal of Rheumatic Diseases | en_HK |
dc.subject | Bone mineral density | en_HK |
dc.subject | Fracture | en_HK |
dc.subject | Osteoporosis | en_HK |
dc.subject | Postmenopausal | en_HK |
dc.subject | Treatment | en_HK |
dc.title | Treatment options for postmenopausal osteoporosis in asia | en_HK |
dc.type | Article | en_HK |
dc.identifier.email | Kung, AWC:awckung@hku.hk | en_HK |
dc.identifier.authority | Kung, AWC=rp00368 | en_HK |
dc.description.nature | link_to_subscribed_fulltext | - |
dc.identifier.doi | 10.1111/j.1756-185X.2008.00389.x | en_HK |
dc.identifier.scopus | eid_2-s2.0-70349492398 | en_HK |
dc.identifier.hkuros | 159054 | en_HK |
dc.relation.references | http://www.scopus.com/mlt/select.url?eid=2-s2.0-70349492398&selection=ref&src=s&origin=recordpage | en_HK |
dc.identifier.volume | 11 | en_HK |
dc.identifier.issue | 4 | en_HK |
dc.identifier.spage | 386 | en_HK |
dc.identifier.epage | 392 | en_HK |
dc.identifier.isi | WOS:000266391800011 | - |
dc.publisher.place | Australia | en_HK |
dc.identifier.scopusauthorid | Chu, EYW=26666500500 | en_HK |
dc.identifier.scopusauthorid | Tsang, SWY=35182014900 | en_HK |
dc.identifier.scopusauthorid | Kung, AWC=7102322339 | en_HK |
dc.identifier.issnl | 1756-1841 | - |